| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $1,574,494 | 5 | 100 |
| Pereira Brian JG | director | 0 | $0 | 5 | $1.57M | $-1.57M |
ProKidney Corp. is a biotechnology firm currently in the clinical trial phase, specializing in the development of innovative cell-based treatments. Their flagship product is Renal Autologous Cell Therapy (RAC-T), a unique cellular admixture derived from a patient's own cells. RAC-T is undergoing significant clinical evaluation; it is concurrently in Phase III and Phase II trials for individuals with moderate to severe diabetic kidney disease. Furthermore, the company is conducting a Phase I clinical trial to assess RAC-T's potential for …
Over the last 12 months, insiders at ProKidney Corp. have bought $0 and sold $1.57M worth of ProKidney Corp. stock.
On average, over the past 5 years, insiders at ProKidney Corp. have bought $25.53M and sold $5.79M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 387,393 shares for transaction amount of $276,366 was made by Control Empresarial de Capitales S.A. de C.V. (Add'l Rep. Persons‑see Ex.99‑1) on 2025‑04‑22.
| 2026-08-20 | Sale | Pereira Brian JG | director | 27,052 0.008% | $1.42 | $38,411 | +16.90% | |
| 2026-08-19 | Sale | Pereira Brian JG | director | 250,000 0.0724% | $1.44 | $360,175 | +12.16% | |
| 2026-08-18 | Sale | Pereira Brian JG | director | 257,164 0.076% | $1.37 | $352,623 | +19.93% | |
| 2025-11-13 | Sale | Pereira Brian JG | director | 54,333 0.0201% | $2.37 | $128,769 | -18.86% | |
| 2025-11-12 | Sale | Pereira Brian JG | director | 255,026 0.0804% | $2.72 | $694,515 | -30.97% | |
| 2025-07-08 | Sale | Weber Darin J. | Chief Regulatory Officer | 103,480 0.0285% | $3.02 | $312,510 | -39.95% | |
| 2025-04-22 | Control Empresarial de Capitales S.A. de C.V. | Add'l Rep. Persons-see Ex.99-1 | 387,393 0.1595% | $0.71 | $276,366 | +199.03% | ||
| 2025-04-17 | Control Empresarial de Capitales S.A. de C.V. | Add'l Rep. Persons-see Ex.99-1 | 25,000 0.0108% | $0.75 | $18,690 | +183.22% | ||
| 2025-04-16 | Control Empresarial de Capitales S.A. de C.V. | Add'l Rep. Persons-see Ex.99-1 | 100,000 0.0432% | $0.75 | $74,820 | +181.44% | ||
| 2025-04-15 | Control Empresarial de Capitales S.A. de C.V. | Add'l Rep. Persons-see Ex.99-1 | 468,000 0.1881% | $0.70 | $326,009 | +215.45% | ||
| 2025-04-14 | Control Empresarial de Capitales S.A. de C.V. | Add'l Rep. Persons-see Ex.99-1 | 268,105 0.1123% | $0.73 | $194,591 | +202.70% | ||
| 2025-04-11 | Control Empresarial de Capitales S.A. de C.V. | Add'l Rep. Persons-see Ex.99-1 | 1,900 0.0007% | $0.61 | $1,155 | +206.30% | ||
| 2025-04-10 | Control Empresarial de Capitales S.A. de C.V. | Add'l Rep. Persons-see Ex.99-1 | 1.03M 0.3622% | $0.61 | $627,692 | +265.12% | ||
| 2024-09-19 | Sale | Weber Darin J. | Chief Regulatory Officer | 16,412 0.007% | $2.50 | $41,030 | -30.54% | |
| 2024-07-26 | Sale | Weber Darin J. | Chief Regulatory Officer | 826 0.0004% | $2.50 | $2,065 | -32.24% | |
| 2024-06-18 | Sale | Weber Darin J. | Chief Regulatory Officer | 17,238 0.0083% | $2.82 | $48,616 | -36.57% | |
| 2024-06-13 | Legorreta Pablo G. | 22.62M 9.3818% | $2.42 | $54.74M | -42.76% | |||
| 2024-06-11 | Control Empresarial de Capitales S.A. de C.V. | Add'l Rep. Persons-see Ex.99-1 | 8.26M 3.4281% | $2.42 | $20M | -29.55% | ||
| 2024-05-20 | Sale | Weber Darin J. | Chief Regulatory Officer | 17,238 0.0121% | $4.08 | $70,386 | -53.74% | |
| 2024-04-22 | Sale | Weber Darin J. | SVP of Regulatory Development | 16,438 0.0071% | $2.51 | $41,315 | -30.33% |
| Control Empresarial de Capitales S.A. de C.V. | Add'l Rep. Persons-see Ex.99-1 | 73842723 21.9604% | $79.01M | 13 | 0 | +27.01% |
| Legorreta Pablo G. | 22617909 6.7264% | $24.2M | 1 | 0 | <0.0001% | |
| Cowen Aaron | 10 percent owner | 6280175 1.8677% | $6.72M | 3 | 0 | +26.12% |
$31,123,523 | 108 | 6.46% | $387.86M | |
$24,384,691 | 42 | -30.27% | $396.82M | |
$140,595,157 | 34 | 17.93% | $301.23M | |
$2,471,510 | 19 | 17.33% | $334.18M | |
$10,399,379 | 13 | 13.60% | $302.03M |
| Increased Positions | 39 | +59.09% | 9M | +26.68% |
| Decreased Positions | 29 | -43.94% | 1M | -2.94% |
| New Positions | 17 | New | 3M | New |
| Sold Out Positions | 14 | Sold Out | 571,526 | Sold Out |
| Total Postitions | 76 | +15.15% | 43M | +23.74% |
| Suvretta Capital Management, Llc | $27,521.00 | 8.69% | 12.34M | 0 | 0% | 2025-09-30 |
| Morgan Stanley | $15,046.00 | 4.75% | 6.75M | +759,481 | +12.68% | 2025-09-30 |
| Bleichroeder Lp | $4,460.00 | 1.41% | 2M | 0 | 0% | 2025-09-30 |
| Millennium Management Llc | $4,363.00 | 1.38% | 1.96M | +2M | New | 2025-09-30 |
| Vanguard Group Inc | $3,488.00 | 1.1% | 1.56M | -3,752 | -0.24% | 2025-09-30 |
| Blackrock, Inc. | $2,848.00 | 0.9% | 1.28M | -487,404 | -27.62% | 2025-09-30 |
| Geode Capital Management, Llc | $2,446.00 | 0.77% | 1.1M | +84,662 | +8.37% | 2025-09-30 |
| Brown University | $2,230.00 | 0.7% | 1M | 0 | 0% | 2025-09-30 |
| Hennion & Walsh Asset Management, Inc. | $2,051.00 | 0.65% | 919,903 | -16,923 | -1.81% | 2025-09-30 |
| Bank Of America Corp /De/ | $1,474.00 | 0.47% | 660,864 | -185,290 | -21.9% | 2025-09-30 |